Picture of Shanghai Bio-heart Biological Technology Co logo

2185 Shanghai Bio-heart Biological Technology Co Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSmall CapSucker Stock

Annual cashflow statement for Shanghai Bio-heart Biological Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-410-231-189-93.3-96
Depreciation
Amortisation
Non-Cash Items32511872.732.726.7
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-16.9-48.545.7-67.1-16.5
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-88.5-141-49-120-67.7
Capital Expenditures-34.7-30-18-47.1-7.64
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.972-70.6-10.91.11-188
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-33.7-101-28.9-46-196
Financing Cash Flow Items-7.27-2.15-0.561-0.322156
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities384-35.2-5.82-2.44154
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash255-257-81.9-167-110